These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 32060059)

  • 21. Characteristics of Alpha-1 Antitrypsin-Deficient Individuals in the Long-term Oxygen Treatment Trial and Comparison with Other Subjects with Chronic Obstructive Pulmonary Disease.
    Stoller JK; Aboussouan LS; Kanner RE; Wilson LA; Diaz P; Wise R;
    Ann Am Thorac Soc; 2015 Dec; 12(12):1796-804. PubMed ID: 26653189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inflammatory cytokine response to exercise in alpha-1-antitrypsin deficient COPD patients 'on' or 'off' augmentation therapy.
    Olfert IM; Malek MH; Eagan TM; Wagner H; Wagner PD
    BMC Pulm Med; 2014 Jun; 14():106. PubMed ID: 24975928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of lung disease in alpha-1 antitrypsin deficiency: a systematic review.
    Edgar RG; Patel M; Bayliss S; Crossley D; Sapey E; Turner AM
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1295-1308. PubMed ID: 28496314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methods of Purification and Application Procedures of Alpha1 Antitrypsin: A Long-Lasting History.
    Viglio S; Iadarola P; D'Amato M; Stolk J
    Molecules; 2020 Sep; 25(17):. PubMed ID: 32887469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alpha-1 antitrypsin augmentation therapy.
    Wewers MD; Crystal RG
    COPD; 2013 Mar; 10 Suppl 1():64-7. PubMed ID: 23527997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alpha 1 Antitrypsin-Deficient Macrophages Have Impaired Efferocytosis of Apoptotic Neutrophils.
    Lee J; Lu Y; Oshins R; West J; Moneypenny CG; Han K; Brantly ML
    Front Immunol; 2020; 11():574410. PubMed ID: 33329539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor necrosis factor-α driven inflammation in alpha-1 antitrypsin deficiency: a new model of pathogenesis and treatment.
    Hurley K; Reeves EP; Carroll TP; McElvaney NG
    Expert Rev Respir Med; 2016 Feb; 10(2):207-22. PubMed ID: 26634397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protease-Specific Biomarkers to Analyse Protease Inhibitors for Emphysema Associated with Alpha 1-Antitrypsin Deficiency. An Overview of Current Approaches.
    Viglio S; Bak EG; Schouten IGM; Iadarola P; Stolk J
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33494436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neutrophil Modulation in Alpha-1 Antitrypsin Deficiency.
    Sapey E
    Chronic Obstr Pulm Dis; 2020 Jul; 7(3):247-259. PubMed ID: 32697897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Biological Effects of Double-Dose Alpha-1 Antitrypsin Augmentation Therapy. A Pilot Clinical Trial.
    Campos MA; Geraghty P; Holt G; Mendes E; Newby PR; Ma S; Luna-Diaz LV; Turino GM; Stockley RA
    Am J Respir Crit Care Med; 2019 Aug; 200(3):318-326. PubMed ID: 30965011
    [No Abstract]   [Full Text] [Related]  

  • 31. SPARTA clinical trial design: exploring the efficacy and safety of two dose regimens of alpha1-proteinase inhibitor augmentation therapy in alpha1-antitrypsin deficiency.
    Sorrells S; Camprubi S; Griffin R; Chen J; Ayguasanosa J
    Respir Med; 2015 Apr; 109(4):490-9. PubMed ID: 25727857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alpha1-antitrypsin deficiency: forgotten etiology.
    Kaplan A; Cosentino L
    Can Fam Physician; 2010 Jan; 56(1):19-24. PubMed ID: 20090075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monocytes and Macrophages in Alpha-1 Antitrypsin Deficiency.
    Belchamber KBR; Walker EM; Stockley RA; Sapey E
    Int J Chron Obstruct Pulmon Dis; 2020; 15():3183-3192. PubMed ID: 33311976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of a Health Management Program on Healthcare Outcomes among Patients on Augmentation Therapy for Alpha 1-Antitrypsin Deficiency: An Insurance Claims Analysis.
    Campos MA; Runken MC; Davis AM; Johnson MP; Stone GA; Buikema AR
    Adv Ther; 2018 Apr; 35(4):467-481. PubMed ID: 29616482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Testing for alpha-1 antitrypsin in COPD in outpatient respiratory clinics in Spain: A multilevel, cross-sectional analysis of the EPOCONSUL study.
    Calle Rubio M; Soriano JB; López-Campos JL; Soler-Cataluña JJ; Alcázar Navarrete B; Rodríguez González-Moro JM; Miravitlles M; Barrecheguren M; Fuentes Ferrer ME; Rodriguez Hermosa JL;
    PLoS One; 2018; 13(6):e0198777. PubMed ID: 29953442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lung Inflammation in alpha-1-antitrypsin deficient individuals with normal lung function.
    Kokturk N; Khodayari N; Lascano J; Riley EL; Brantly ML
    Respir Res; 2023 Feb; 24(1):40. PubMed ID: 36732772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bronchoscopic Lung Volume Reduction in Patients with Emphysema due to Alpha-1 Antitrypsin Deficiency.
    Everaerts S; Hartman JE; Van Dijk M; Koster TD; Slebos DJ; Klooster K
    Respiration; 2023; 102(2):134-142. PubMed ID: 36549279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Role of Neutrophils in Alpha-1 Antitrypsin Deficiency.
    McCarthy C; Reeves EP; McElvaney NG
    Ann Am Thorac Soc; 2016 Aug; 13 Suppl 4():S297-304. PubMed ID: 27564664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. α1 Antitrypsin deficiency: current best practice in testing and augmentation therapy.
    Campos MA; Lascano J
    Ther Adv Respir Dis; 2014 Oct; 8(5):150-61. PubMed ID: 25013223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ICS Use May Modify FEV1 Decline in α1-Antitrypsin Deficiency Patients with Relatively High Blood Eosinophils.
    Low EV; Hughes SM; Zaffarullah S; Kantas D; Stockley RA; Turner AM
    Respiration; 2018; 95(2):114-121. PubMed ID: 29253843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.